United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...

A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...

On Friday, doctors at Massachusetts General Hospital announced that a 66-year-old New Hampshire man had successfully received ...

The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...

Surgeons at Massachusetts General Hospital have successfully performed the fourth pig kidney transplant in the U.S.

His effort paid off: Tim Andrews, 66, is only the second person known to be living with a pig kidney. Andrews is free from ...

Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), a $15.77 billion market cap company with an "Excellent" financial health rating according to InvestingPro, executed a ...

Both United Therapeutics and eGenesis have extensively modified pig genes to enhance compatibility and reduce the likelihood of organ rejection. This approach aims to create a viable long-term ...

David-Alexandre C. Gros, MD, CEO at Eledon, discusses the milestone and the role of immunosuppression regimens for durable ...

HealthDay News — The US Food and Drug Administration (FDA) has approved the first-ever clinical trials testing pig kidney transplants in people with kidney failure, marking a major step forward in ...